Detalhe da pesquisa
1.
Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors.
Blood
; 143(10): 858-865, 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38194683
2.
Proteomic Characterization Identifies Clinically Relevant Subgroups of Gastrointestinal Stromal Tumors.
Gastroenterology
; 166(3): 450-465.e33, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37995868
3.
A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia.
Blood
; 141(22): 2738-2755, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36857629
4.
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option.
Blood
; 142(1): 73-89, 2023 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37018663
5.
TRIM21/USP15 balances ACSL4 stability and the imatinib resistance of gastrointestinal stromal tumors.
Br J Cancer
; 130(4): 526-541, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38182686
6.
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape.
Ann Hematol
; 103(5): 1561-1568, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38321229
7.
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST.
Cell Commun Signal
; 22(1): 153, 2024 02 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38414063
8.
Navigating the Management of Chronic Phase CML in the Era of Generic BCR::ABL1 Tyrosine Kinase Inhibitors.
J Natl Compr Canc Netw
; 22(1)2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38394773
9.
Chronic myeloid leukemia (CML) in children and adolescents-Clinicopathological findings.
Eur J Haematol
; 112(3): 458-465, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37985225
10.
Gastric gastrointestinal stromal tumors: therapeutic strategies and long-term prognosis.
Scand J Gastroenterol
; 59(2): 239-245, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37865826
11.
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry.
Gastric Cancer
; 27(2): 355-365, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38146035
12.
FBXW7 regulates the sensitivity of imatinib in gastrointestinal stromal tumors by targeting MCL1.
Gastric Cancer
; 27(2): 235-247, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38142463
13.
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial.
Crit Care
; 28(1): 65, 2024 02 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38424569
14.
Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer.
Mol Ther
; 31(2): 503-516, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36384875
15.
miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34 + cells partially via SERPINE1.
Cell Mol Life Sci
; 81(1): 10, 2023 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38103082
16.
Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies.
Cell Mol Life Sci
; 80(9): 248, 2023 Aug 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37578596
17.
DIA-Based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid Leukemia.
Mol Cell Proteomics
; 21(2): 100187, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34922009
18.
Development of a simultaneous quantification method of imatinib and sunitinib and their main metabolites and its application in patients with gastrointestinal stromal tumor.
Biomed Chromatogr
; 38(3): e5804, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38152034
19.
[Discontinuation of tyrosine kinase inhibitors before epiphyseal closure leading to improved short stature in pediatric chronic myelogenous leukemia].
Rinsho Ketsueki
; 65(3): 175-179, 2024.
Artigo
Japonês
| MEDLINE | ID: mdl-38569862
20.
[A case of heritable pulmonary arterial hypertension treated with long-term oral low-dose imatinib].
Zhonghua Jie He He Hu Xi Za Zhi
; 47(1): 36-38, 2024 Jan 12.
Artigo
Chinês
| MEDLINE | ID: mdl-38062692